SUMMARY The effect of four weeks and 15 months of treatment with the cardioselective beta-receptor antagonist metoprolol on blood pressures, plasma noradrenaline, adrenaline, and dopamine at rest, during submaximal steady state and near maximal exercise, as well as five minutes after exercise, was studied in seven moderately hypertensive men aged 25 to 51 years.
The exercise-induced increase in plasma noradrenaline and adrenaline tended to be more pronounced after treatment with metoprolol with virtually identical values after both four weeks and 15 months. Plasma dopamine was much less affected by exercise and showed only a weak tendency towards higher values during work. While no significant changes were observed after four weeks of treatment, there was a significant 10 to 12 fold increase of dopamine over the control values after 15 months of treatment. At rest plasma dopamine was five and 10 times higher than corresponding noradrenaline and adrenaline levels. The excessive rise of dopamine might have clinical implications: because of the cardiovascular and renal actions of dopamine, high levels should tend towards dampening the negative inotropic effect of beta-receptor blockade and might thus contribute to the increase of cardiac output and decrease of peripheral vascular resistance usually seen with beta-receptor antagonists after longterm treatment compared with acute or short-term administration. (Table) .
The exercise-induced increase of plasma noradrenaline tended to be more pronounced after treatment with metoprolol; individual and mean values were virtually identical at four weeks and 15 months (Fig. 1) .
The effect on plasma adrenaline was similar; the rise as observed particularly during near-maximal work was of the same order after four weeks and 15 months (Fig. 2) .
The levels of plasma dopamine were much less affected by exercise (Fig. 3 ) and showed only a weak tendency towards higher values during exercise. While no significant changes were observed after four weeks of treatment, there was a significant (p < 0-001) 10 to 12 fold increase of plasma dopamine over control values after 15 months of treatment with roughly identical levels during all conditions. group.bmj.com on September 10, 2017 -Published by http://heart.bmj.com/ Downloaded from Plasma dopamine increase during long-term beta-adrenoreceptor blockade At rest, before exercise, plasma dopamine was five and 10 times higher than corresponding plasma noradrenaline and adrenaline levels (Fig. 4) Fig. 4 Means of plasma noradrenaline, adrenaline, and dopamine at rest supine; during submaximal and near-maximal work; andfive minutes after exercise; after a 15-month period of treatment with metoprolol. group.bmj.com on September 10, 2017 -Published by http://heart.bmj.com/ Downloaded from pulse rate and systolic blood pressure reduction was almost identical after the four-week and 15-month periods. Only diastolic pressures showed a tendency towards a further slight decrease after 15 months compared with four weeks of treatment.
The fairly constant effect of treatment on the circulation during standardised exercise as evident from the similar pulse rates and blood pressures observed at four weeks and 15 months of treatment is particularly worth noting as it is of great importance when the response of plasma catecholamines to exercise and to treatment of different durations is to be evaluated.5
The changes in plasma noradrenaline and adrenaline observed after four weeks of betareceptor blockade in the present series agree with the results reported by other authors.' 312 The results obtained at four weeks and 15 months, respectively, in our patients indicate that the changes in both plasma noradrenaline and adrenaline induced by beta-receptor blockade remain virtually constant independently of the duration of treatment. Despite unchanged levels of plasma noradrenaline, the diastolic blood pressure tended to be slightly lower after 15 months compared with that at four weeks. This might suggest that levels of circulating noradrenaline do not play a primary or decisive role in the mechanism of the antihypertensive effect exerted by beta-receptor blocking agents.5 Even adrenaline does not seem to be of major importance in this respect. The increase of plasma adrenaline after beta-receptor blockade, in particular under conditions of near maximal exercise, reflects a compensatory mechanism aimed at coping with the restricted glycogen breakdown in the working muscle during heavy work.2' Plasma dopamine was virtually unchanged after four weeks of metoprolol administration but it showed a considerable rise after 15 months of treatment. The dopamine levels attained are of such an order that haemodynamic effects resulting from the specific properties of dopamine,7 are likely to occur'3 and might have clinical implications. Dopamine has a positive effect on the cardiac contractility resulting in a significant increase in stroke volume and cardiac output.7 8 13 Furthermore, dopamine is a potent vasodilator of the renal vascular bed inducing increased perfusion mainly in the renal medulla'4 and a significant enhancement of sodium excretion.6 7 Because of these specific effects high levels of dopamine should tend towards dampening the negative inotropic effect of chronic beta-receptor blockade. Hence it might contribute to the increase of cardiac output and the decrease of peripheral vascular resistance seen after longterm treatment compared with acute or short-term administration of most beta-receptor blockers,"5 16 and even alpha-beta-receptor blockers.'7 Furthermore, the high levels of dopamine may tend to counterbalance the reduced hypothalamic dopaminergic activity shown to occur in hypertensives and to be influenced by the dopaminergic agonist bromocriptine."8
It is important to underline that these findings are preliminary; since different beta-receptor blockers may have different effects on plasma catecholamines' they may not apply to all betareceptor antagonists. Thus, the finding of an excessive dopamine increase during chronic adrenergic beta-receptor blockade requires further confirmation and research.
